Other Information.
+Added: Executive Employment Agreement, dated November 8, 2021, by and between the Company and Robert Hoffman (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on November 12, 2021).
+Added: Second Amended Employment Agreement, dated November 8, 2021, by and between the Company and Saiid Zarrabian (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on November 12, 2021).
Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
13 unchanged sentences
Kintara Therapeutics, Inc.
−Removed: November 15, 2021
+Added: February 11, 2022
/s/ Robert E.
1 unchanged sentence
(Principal Executive Officer)
−Removed: November 15, 2021
+Added: February 11, 2022
/s/ Scott Praill
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.